Scientists can't figure out mysterious signal from deep space
Scientists have detected a mysterious, regular signal, named ASKAP J1832-0911, flashing from 15,000 light years away in space, emitting radio waves and X-rays every 44 minutes.
The object was discovered using an Australian telescope and NASA 's Chandra X-ray Observatory, marking the first time an LPT (long-period transient) has been observed emitting both X-rays and radio signals.
Researchers note that the X-ray and radio wave emissions from ASKAP J1832-0911 have decreased over time, an unprecedented phenomenon in the Milky Way galaxy.
The nature of the object remains unknown, with theories suggesting it could be a magnetar or a binary star system involving a highly magnetised white dwarf, but these theories do not fully explain the observed behaviour.
Scientists aim to continue studying ASKAP J1832-0911 and search for similar objects, hoping the X-ray emissions will provide insights into the origin and mechanism of the signals, potentially indicating new physics or stellar evolution models.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
34 minutes ago
- Reuters
What do ancient Egyptian mummies smell like?
Scientists have found that ancient Egyptian mummified bodies emit woody, spicy, and sweet aromas, offering fresh insights into the mummification process, practices and materials. David Doyle has more.
The Guardian
8 hours ago
- The Guardian
‘Breakthrough' breast cancer therapy can slow advance of disease and prolong survival
A new triple therapy for aggressive, advanced breast cancer slows the progression of the disease, delays the need for further chemotherapy and helps patients live longer, research reveals. The combination treatment is made up of two targeted drugs: inavolisib and palbociclib, and the hormone therapy fulvestrant. It improved overall survival by an average of seven months, compared with the patients in the control group, who were given palbociclib and fulvestrant. It also delayed progression of the disease by 17.2 months, on average, compared with 7.3 months in the control group, and patients taking inavolisib were able to delay subsequent chemotherapy treatment by almost two years longer than the patients in the control group. The results of the study, funded by Roche, were presented at the American Society of Clinical Oncology (Asco) annual meeting in Chicago and published in the New England Journal of Medicine. The international trial involved 325 patients from 28 countries, including the US, UK, Australia, Singapore, Brazil, France and Germany. Experts said it demonstrated the potential of the triple therapy for targeting PIK3CA-mutated HR+, HER2- breast cancer – a common form of the disease. About 70% of patients have HR+, HER2- breast cancer. PIK3CA mutations are found in 35% to 40% of HR+ breast cancers, and are linked to tumour growth, disease progression and treatment resistance. 'The INAVO120 trial has identified a targeted treatment regimen that meaningfully improves survival in patients with untreated PIK3CA-mutated hormone receptor-positive metastatic breast cancer – a big step forward for these patients,' said Dr Jane Lowe Meisel, the co-director of breast medical oncology at Winship Cancer Institute of Emory University, and an Asco expert in breast cancer. The results also showed a substantial shrinking in cancer growth in about 62.7% of patients in the triple therapy group compared with 28% in the control group. Dr Simon Vincent, the director of research, support and influencing at Breast Cancer Now, said the findings were a 'significant breakthrough'. Dr Nisharnthi Duggan, a research information manager at Cancer Research UK, said: 'These results are really positive news for people living with a type of hard-to-treat breast cancer. 'The trial showed that adding inavolisib to targeted treatment plans improved survival. On top of this, it also delayed the progression of people's cancer and the need for chemotherapy, which could improve quality of life. We hope that more research like this will help to give people kinder cancer treatment options, and more time with their loved ones.' In the trial, more than half of the patients had disease that had already spread to three or more organs. The researchers used circulating tumour DNA (ctDNA) liquid biopsy blood tests to determine whether patients had a PIK3CA mutation. Participants were then allocated to receive either the inavolisib-based regimen or a combination of palbociclib, fulvestrant and a dummy pill. The new drug inavolisib works by blocking the activity of the PIK3CA protein. The inavolisib combination was generally well tolerated with only a few patients experiencing side-effects that led them to discontinue the treatment. Nick Turner, professor of molecular oncology at the Institute of Cancer Research, London, and consultant medical oncologist at the Royal Marsden NHS Foundation Trust, led a UK arm of the trial. 'The key findings from this study showed that the inavolisib-based therapy not only helped patients live longer but it more than doubled the time before their cancer progressed or worsened. It also gave them more time before needing subsequent chemotherapy which we know is something that patients really fear and want to delay for as long as possible. 'These results give us confidence that this treatment could become the new go-to option for patients who have HR+, HER2- breast cancer with a PIK3CA mutation, as it has shown significant improvements in both survival and quality of life.'
BBC News
10 hours ago
- BBC News
Are seed oils really bad for you?
Seed oils like canola and sunflower oil have attracted controversial claims about harmful effects in recent times. Is there any truth to them? You might have a bottle of sunflower oil or canola (rapeseed) oil stashed away in a kitchen cupboard somewhere. Whether you cook with them or drizzle them over salads, seed oils are popular across the world. But these unassuming seed oils have become the centre of a heated debate online. In recent years, seed oils have become the target of countless social media posts, with people claiming that they are "toxic", "poisonous" and, ultimately, are damaging our health. Critics have nicknamed some seed oils 'the hateful eight' – referencing eight popular seed oils, canola, corn, cottonseed, grapeseed, soy, rice bran, sunflower and safflower – and blame them for causing heart disease and type 2 diabetes. Are seed oils really the enemy, or is the antagonism towards them unjustified? Are seed oils connected to heart health? Much of the recent criticism of seed oils focuses on their high omega-6 fatty acid content. Omega 6 fatty acids are essential fatty acids, which means we need them, but can't produce them ourselves. In recent years some scientists have argued that omega 6 can cause chronic inflammation (which can increase the risk of developing diseases including heart disease and cancer). But controlled trials have found that omega-6 fatty acids do not increase inflammation, says Dariush Mozaffarian, professor and director of the Food is Medicine Institute at Tufts University in Massachusetts in the US. "New research shows that omega-6 fatty acids give rise to unique natural molecules, like lipoxins, that have powerful anti-inflammatory effects in the body," says Mozaffarian. Recent research studied the diet and health of over 200,000 people in the US for around 30 years. The researchers found that people who consumed more plant oils (including seed oils) were less likely to die from cardiovascular disease or cancer over the course of the study. On the other hand, those with a higher intake of butter were more likely to die during the same period. There are numerous observational studies looking at how omega 6 effects our heart health – where scientists look at data on diet and health, and find associations between the two. But some observational studies rely on people's own accounts of what they eat, says Matti Marklund, assistant professor of human nutrition at Johns Hopkins Bloomberg School of Public Health in the US. And this, he adds, can be problematic because people may misremember, or even be dishonest, about their dietary habits. Another way to measure omega 6 intake is to measure the average amount in the individual components and ingredients in a person's diet. However, Marklund adds, it can be difficult to translate what people say they have eaten into certain quantities. Numerous studies investigating the effects of omega 6 on our health focus on linoleic acid, an omega 6 fatty acid found in high amounts in seed oil, that has been found to lower the 'bad' LDL cholesterol in our blood. In a 2019 study, Marklund instead focused on the levels of fatty acids in the blood of participants from around 30 observational studies – some which followed people for up to 30 years – and looked at how many developed cardiovascular disease and died from it. He found that those with the highest levels of linoleic acid in blood had the lowest risk of developing cardiovascular disease. There is some confusion regarding omega 6 and heart health, says Christopher Gardner, director of nutrition studies at the Stanford Prevention Research Center in the US. This partly stems from omega 6's role in the process of blood clotting, which Gardner says people mistakenly only associate with strokes and heart attacks. Omega 3, he says, tends to be more blood-thinning. "If you had a wound in your hand, you'd want it to clot," he says. "You need balance." Meanwhile, scientists concluded in a 2019 analysis of 30 studies that people with higher amounts of linoleic acid in their blood were 7% less likely to develop heart disease. "Linoleic [acid] might improve cholesterol to reduce the risk of cardiovascular disease, and also improve glucose metabolism, which reduces the risk of type 2 diabetes," Marklund says. Seed oils and the 3:6 ratio Another common accusation levelled at seed oils is that eating too much omega 6 compared to omega 3 is harmful. In the Western world, omega-6 fatty acids account for around 15% of our total energy intake. The average person's ratio of omega 3 to omega 6 can be up to 50:1. However, it should be more like 4:1 to reduce our risk of cardiovascular disease, according to one study. A 2022 World Health Organization review and meta-analysis reported that a higher omega 6:3 ratio was associated with a greater risk of cognitive decline and ulcerative colitis, a chronic inflammatory bowel disease. On the other hand, a higher omega 3:6 ratio was also linked to a 26% reduced risk of depression. Overall, the scientists involved in the WHO study concluded that a high intake of omega 6 fatty acids from seed oils is unlikely to increase your risk of death and disease – but say that more high-quality research is needed. But while some scientists argue that you shouldn't have too much omega 6 compared to omega 3, Marklund says it's better to up your intake of omega 3 rather than consume less omega 6, as both are associated with health benefits. How seed oils are processed Unlike other oils, seed oils are extracted from the seeds of plants. There are some concerns that seed oils are extracted with hexane – a chemical made from crude oil – but there is little evidence so far suggesting that this process can cause issues. While some evidence suggests hexane could be linked to several health conditions, after being extracted, the oil is then deodorised and bleached to remove and additives. "Scientists will say hexane extract is normal in food processing, and the deodorising and bleaching removes potentially harmful compounds," says Gardner. Cold-pressed seed oils avoid this process entirely, as it involves squeezing the seeds to extract the oil – but this results in a more expensive product. Can seed oils fuel tumour growth? Despite an abundance of research showing the potential benefits omega 6 might have to our health, researchers have recently found that this fatty acid can fuel the growth of a specific type of breast cancer. The findings may have implications for the impact of omega 6 consumption on other diseases, too. Cancer cells use nutrients as fuel to grow and multiply, but until now, there was limited research looking at the role omega 6 fatty acids play. But a study published in March this year found a mechanism by which linoleic acid, an omega 6 fatty acid, helps cancer cells to grow and multiply in patients with triple negative breast cancer (TNBC). This is the most aggressive sub-type of the disease, and one that doesn't respond well to targeted therapies. Previous studies suggest there is no association with omega 6 fatty acids, or a small increase in risk, says Nikolaos Koundouros, postdoctoral associate at Weill Cornell Medicine research centre in New York. But these studies, he says, haven't taken into account that there are multiple sub-types of breast cancer, and that they all differ in terms of a patient's survival and prognosis, and how they might respond to targeted therapy. TNBC seems to respond the most to omega 6 linoleic acid, Koundouros says. Along with a team of researchers, Koundouros discovered in the lab that, when fed omega 6, TNBC cells activate a protein complex linked to tumour growth and progression. Another protein, which is found in larger amounts in TNBC tumours compared to other breast cancer subtypes, is known to take fatty acids and lipids throughout the body and within cells to exactly where they need to be. Koundouros explains that these proteins, along with omega 6, may also be relevant in other chronic diseases, such as obesity and type 2 diabetes. This research could potentially inform treatment options for TNBC patients, but it doesn't necessarily have wider implications for everyone, Koundouros says. "It's important to remember omega 6 fats are essential for a reason; if you completely cut them out, you could have detrimental side effects," he says. Which seed oil? Some seed oils – such as canola oil and soybean oil – have been studied more than others, so have a more rigorous evidence base. "These each provide a balanced combination of healthy fats, including monounsaturated fats, omega-6 polyunsaturated fats, and omega-3 polyunsaturated fats," Mozaffarian says. Canola oil, Mozaffarian adds, has similar anti-inflammatory effects and produces better improvements in blood cholesterol levels than olive oil, which has long been hailed the healthiest of all oils. One meta-analysis of 27 trials found that canola oil was found to significantly reduce LDL cholesterol compared to sunflower oil and saturated fat, while another found that it dramatically reduced body weight, especially in in those with type 2 diabetes. "Canola oil produces excellent benefits for blood cholesterol levels, and also modestly reduces body weight. The healthy fats in canola oil, especially the omega 6 polyunsaturated fats, also improve blood glucose, insulin resistance, and insulin production," says Mozaffarian. Soybean oil has also been found to improve cholesterol levels compared to saturated fats. One study found that people who consumed more soybean oil had lower risk of death from all causes; a 6% lower risk for every 5g they consumed daily. Which seed oil is healthiest? "Seeds are one of nature's most nourishing gifts; a package of beneficial healthy fats," says Mozaffarian. That something so well studied within nutrition science has had such a backlash has been a source of confusion for some scientists. But this misunderstanding may come from a "misplaced combination of partial truths", Mozaffarian says. For instance, some people may link seed oils to ultra-processed foods (UPFs), which often contain seed oils, particularly canola, corn, soybean, and sunflower oils. In recent years there has been a huge focus on the health risks of consuming too many UPFs, including increased risk of developing type two diabetes and heart disease. More like this:• What is the healthiest cooking oil?• The truth about saturated fat• Cod liver oil: The fishy fix that was surprisingly healthy "But these dangers arise from too much starch, sugar, and salt, loss of natural intact food structure and dozens, or even hundreds, of artificial additives," Mozaffarian says. Some people have also drawn a correlation with increased consumption of seed oils in recent years and the rise in obesity and diabetes. "But if you want to draw parallels with people eating more seed oils and unhealthy outcomes, it's because we're eating food that tends to contain a lot of sugar and sodium," Gardner suggests. He says there are many ways to consume seed oils at home that don't involve UPFs, such as with a salad or stir-fry. "I'd hate to see people tossing out seed oils because of this seed oil war," says Gardner. Ultimately, while some scientists call for more rigorous trials looking into the effects of seed oil consumption on our health, others, including Marklund, argue that there is already a wealth of good quality trials showing benefits on blood cholesterol, blood glucose and insulin levels for the general population. "Omega-6 fatty acids are excellent for health," says Marklund. "They have been linked to lower onset of heart disease, stroke, diabetes, and even death from all causes." -- For trusted insights into better health and wellbeing rooted in science, sign up to the Health Fix newsletter, while The Essential List delivers a handpicked selection of features and insights. For more science, technology, environment and health stories from the BBC, follow us on Facebook, X and Instagram.
